Fresenius | FRE - Assets

Stock Price
49.49
Daily Change
0.50 1.03%
Monthly
3.78%
Yearly
33.26%
Q1 Forecast
45.82

Fresenius reported EUR42.46B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Akzo Nobel EUR 13.95B 55M Dec/2025
Alcon AG USD 31.52B 137M Sep/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
BASF EUR 76.44B 1.23B Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Beiersdorf EUR 12.92B 87M Jun/2025
DaVita Healthcare Partners USD 17.56B 62.93M Sep/2025
Demant DKK 39.07B 6.43B Dec/2025
E.ON EUR 107.04B 2.4B Sep/2025
Essilor EUR 61.93B 2.34B Jun/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Fresenius Medical Care EUR 30.89B 404.18M Sep/2025
Getinge SEK 63.92B 4.3B Dec/2024
Givaudan CHF 12.18B 1.05B Jun/2024
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
GN Store Nord DKK 29.06B 436M Sep/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 50.93B 3.58B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Philips EUR 26.34B 40M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
RWE EUR 96.2B 1.6B Sep/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025